Taken together, the data lend further support to the Kamoun hypothesis, i.e., that excess H2S in DS contributes to the pathophysiological neurological events and that pharmacological inhibition of CBS may be of potential future therapeutic utility in this condition. This evidence concerns the gene CBS and Dravet syndrome.